Skip to content

Clinical trials

Connective Tissue Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20112
20151
20161
20171
20194
20223
20232
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Terminated2
Enrolling by invitation2
Active, not recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Amgen2
Bristol-Myers Squibb2
United Therapeutics2
AbbVie1
AstraZeneca1
Biogen1
CHU de Quebec-Universite Laval1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases22
Immune System Diseases7
Autoimmune Diseases6
Arthritis, Rheumatoid5
Arthritis4
Lupus Erythematosus, Systemic4
Skin Diseases4
Hypertension, Pulmonary3
Lung Diseases3
Lung Diseases, Interstitial3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.